Reagentia en instrumenten voor immunologie, celbiologie en moleculaire biologie.
 
> BMS-986313 is a potent, selective, orally active RORγt inverse agonist with EC50 of 3.6 nM in GAL-4 reporter assay in Jurkat cell line, and 50 nM in IL-17 human whole blood assay.BMS-986313 demonstrated robust efficacy in preclinical models of psoriasis (the IMQ-induced skin lesion model and the IL-23-induced acanthosis model).

BMS-986313 is a potent, selective, orally active RORγt inverse agonist with EC50 of 3.6 nM in GAL-4 reporter assay in Jurkat cell line, and 50 nM in IL-17 human whole blood assay.BMS-986313 demonstrated robust efficacy in preclinical models of psoriasis (the IMQ-induced skin lesion model and the IL-23-induced acanthosis model).

Afdrukken Afdrukken
Log in alstublieft

Referentie orb1910405-100mg

Formaat : 100mg

Merk : Biorbyt

Neem contact op met een lokale distributeur :


Telefoonnummer : +1 850 650 7790